1. Abrantes J, van der Loo W, Le Pendu J, Esteves PJ. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res. 2012; 43:12.
Article
2. Abrantes J, Lopes AM, Esteves PJ. Complete genomic sequences of rabbit hemorrhagic disease virus G1 strains isolated in the European rabbit original range. J Virol. 2012; 86:13886.
Article
3. Bertagnoli S, Gelfi J, Le Gall G, Boilletot E, Vautherot JF, Rasschaert D, Laurent S, Petit F, Boucraut-Baralon C, Milon A. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J Virol. 1996; 70:5061–5066.
Article
4. Bertagnoli S, Gelfi J, Petit F, Vautherot JF, Rasschaert D, Laurent S, Le Gall G, Boilletot E, Chantal J, Boucraut-Baralon C. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine. 1996; 14:506–510.
Article
5. Castanón S, Marín MS, Martín-Alonso JM, Boga JA, Casais R, Humara JM, Ordás RJ, Parra F. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J Virol. 1999; 73:4452–4455.
Article
6. Chen Z, Li C, Zhu Y, Wang B, Meng C, Liu G. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein. Virus Res. 2012; 169:306–309.
Article
7. Farnós O, Fernández E, Chiong M, Parra F, Joglar M, Méndez L, Rodríguez E, Moya G, Rodríguez D, Lleonart R, González EM, Alonso A, Alfonso P, Suárez M, Rodríguez MP, Tholedo JR. Biochemical and structural characterization of RHDV capsid protein variants produced in
Pichia pastoris: advantages for immunization strategies and vaccine implementation. Antiviral Res. 2009; 81:25–36.
Article
8. Fernández E, Toledo JR, Chiong M, Parra F, Rodríguez E, Montero C, Méndez L, Capucci L, Farnós O. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. Vet Immunol Immunopathol. 2011; 142:179–188.
Article
9. Fischer L, Le Gros FX, Mason PW, Paoletti E. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine. 1997; 15:90–96.
Article
10. Forrester NL, Abubakr MI, Abu Elzein EME, al-Afaleq AI, Housawi FMT, Moss SR, Turner SL, Gould EA. Phylogenetic analysis of
Rabbit haemorrhagic disease virus strains from the Arabian Peninsula: Did RHDV emerge simultaneously in Europe and Asia? Virology. 2006; 344:277–282.
Article
11. Forrester NL, Moss SR, Turner SL, Schirrmeier H, Gould EA. Recombination in rabbit haemorrhagic disease virus: possible impact on evolution and epidemiology. Virology. 2008; 376:390–396.
Article
12. Gould AR, Kattenbelt JA, Lenghaus C, Morrissy C, Chamberlain T, Collins BJ, Westbury HA. The complete nucleotide sequence of rabbit haemorrhagic disease virus (Czech strain V351): use of the polymerase chain reaction to detect replication in Australian vertebrates and analysis of viral population sequence variation. Virus Res. 1997; 47:7–17.
Article
13. Gregg D, House C, Meyer R, Berninger M. Viral haemorrhagic disease of rabbits in Mexico: epidemiology and viral characterization. Rev Sci Tech. 1991; 10:435–451.
Article
14. Gromadzka B, Szewczyk B, Konopa G, Fitzner A, Kęsy A. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus. Acta Biochim Pol. 2006; 53:371–376.
Article
15. Kim MS, Sin JI. Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model. Immunology. 2005; 116:255–266.
Article
16. Liu G, Zhang Y, Ni Z, Yun T, Sheng Z, Liang H, Hua J, Li S, Du Q, Chen J. Recovery of infectious rabbit hemorrhagic disease virus from rabbits after direct inoculation with in vitro-transcribed RNA. J Virol. 2006; 80:6597–6602.
Article
17. Liu S, Xue H, Pu B, Qian N. A new viral disease in rabbits. Anim Husb Vet Med. 1984; 16:253–255.
18. Marín MS, Martín Alonso JM, Pérez Ordoyo García LI, Boga JA, Argüello-Villares JL, Casais R, Venugopal K, Jiang W, Gould EA, Parra F. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine. Virus Res. 1995; 39:119–128.
Article
19. McIntosh MT, Behan SC, Mohamed FM, Lu Z, Moran KE, Burrage TG, Neilan JG, Ward GB, Botti G, Capucci L, Metwally SA. A pandemic strain of calicivirus threatens rabbit industries in the Americas. Virol J. 2007; 4:96.
Article
20. Meyers G, Wirblich C, Thiel HJ. Genomic and subgenomic RNAs of rabbit hemorrhagic disease virus are both protein-linked and packaged into particles. Virology. 1991; 184:677–686.
Article
21. Meyers G, Wirblich C, Thiel HJ. Rabbit hemorrhagic disease virus-molecular cloning and nucleotide sequencing of a calicivirus genome. Virology. 1991; 184:664–676.
Article
22. Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ, Vijayachari P, Weiner DB. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine. 2008; 26:5128–5134.
Article
23. Mutze G, Cooke B, Alexander P. The initial impact of rabbit hemorrhagic disease on European rabbit populations in South Australia. J Wildl Dis. 1998; 34:221–227.
Article
24. Nowotny N, Bascuñana CR, Ballagi-Pordaány A, Gavier-Widén D, Uhlén M, Belák S. Phylogenetic analysis of rabbit haemorrhagic disease and European brown hare syndrome viruses by comparison of sequences from the capsid protein gene. Arch Virol. 1997; 142:657–673.
Article
25. Pérez-Filgueira DM, Resino-Talaván P, Cubillos C, Angulo I, Barderas MG, Barcena J, Escribano JM. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV. Virology. 2007; 364:422–430.
Article
26. Rohde J, Schirrmeier H, Granzow H, Rziha HJ. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV). Vaccine. 2011; 29:9256–9264.
Article
27. Tokuoka M, Tanaka M, Ono K, Takagi S, Shintani T, Gomi K. Codon optimization increases steady-state mRNA levels in
Aspergillus oryzae heterologous gene expression. Appl Environ Microbiol. 2008; 74:6538–6546.
Article
28. Wirblich C, Meyers G, Ohlinger VF, Capucci L, Eskens U, Haas B, Thiel HJ. European brown hare syndrome virus: relationship to rabbit hemorrhagic disease virus and other caliciviruses. J Virol. 1994; 68:5164–5173.
Article
29. Zhi N, Wan Z, Liu X, Wong S, Kim DJ, Young NS, Kajigaya S. Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells. J Virol. 2010; 84:13059–13062.
Article